Benzinga | Nov 9, 2021 04:22PM EST

Celldex Therapeutics Q3 EPS $(0.45) Down From $(0.36) YoY, Sales $153.00K Down From $668.00K YoY

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.45) per share. This is a 25 percent decrease over losses of $(0.36) per share from the same period last year. The company reported $153.00 thousand in sales this quarter. This is a 77.10 percent decrease over sales of $668.00 thousand the same period last year.